The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.
As the CBD Pure Hemp Oil label warns, you should not take the supplement if you are breastfeeding or pregnant, as there isn’t enough information on how it could affect the baby. Also, some studies suggest a long-term heavy use of cannabis can have negative neuropsychologic and behavioral effects, and even cause acute pancreatitis, although the exact mechanisms are still unknown.
I use this for my anxiety and for my arthritis. The topical works great for my chronic neck pain. The best way to go is to get your own raw, tested material and use it in whatever form you like. It’s quite easy to make your own extract. This has worked better for me, rather than relying on a purchased, untested product – where some seem to work and others are a waste. But even with those that work, of course the cost is ridiculous and not affordable, thanks to all these corporate-pleasing laws in place, not there for the people – don’t delude yourselves.
We’ve linked to the best, most reputable source for each one of these products (most frequently the manufacturer’s site). While you may want to shop around (and we encourage it!), we recommend that you buy from one of our preferred sites. That way you’ll know that you’re getting an authentic product at a reasonable price, from a company that actually stands behind their product.
Studies have demonstrated that CBD has a low affinity for the CB1 receptors, but even at low concentrations, CBD decreases G-protein activity (3). CB1 receptors are expressed on many glutamatergic synapses that have been implicated in seizure threshold modulation. CBD may act at CB1 receptors to inhibit glutamate release (4). Studies have shown changes in the expression of CB1 receptors during epileptogenesis and after recurrent seizures (5). CB1 receptor expression is upregulated at GABAergic synapses and shown to be downregulated at glutamatergic synapses in epilepsy, contributing to lowering seizure thresholds.